Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark D, Jesky"'
Autor:
Nadezhda A Wall, C Coral Dominguez-Medina, Sian E Faustini, Charlotte N Cook, Andrew McClean, Mark D Jesky, Marisol Perez-Toledo, Matthew D Morgan, Alexandra G Richter, Charles J Ferro, Paul Cockwell, Paul A Moss, Ian R Henderson, Lorraine Harper, Adam F Cunningham
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195730 (2018)
Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To exa
Externí odkaz:
https://doaj.org/article/b478c3608469450ab171c537a903e74b
Autor:
Anthony Fenton, Mark D Jesky, Rachel Webster, Stephanie J Stringer, Punit Yadav, Iain Chapple, Indranil Dasgupta, Stephen J Harding, Charles J Ferro, Paul Cockwell
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197043 (2018)
Patients with chronic kidney disease (CKD) are at an increased risk of developing end-stage renal disease (ESRD). We assessed for the first time whether urinary free light chains (FLC) are independently associated with risk of ESRD in patients with C
Externí odkaz:
https://doaj.org/article/e49bff4fa88143b28a813b2ff1375d06
Autor:
Anthony Fenton, Mark D Jesky, Charles J Ferro, Jacob Sørensen, Morten A Karsdal, Paul Cockwell, Federica Genovese
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175200 (2017)
BACKGROUND:Patients with chronic kidney disease (CKD) are at increased risk of end-stage renal disease (ESRD) and early mortality. The underlying pathophysiological processes are not entirely understood but may include dysregulation of extracellular
Externí odkaz:
https://doaj.org/article/43161efcf7384538a3e3edd835720e71
Autor:
Mark D Jesky, Mary Dutton, Indranil Dasgupta, Punit Yadav, Khai Ping Ng, Anthony Fenton, Derek Kyte, Charles J Ferro, Melanie Calvert, Paul Cockwell, Stephanie J Stringer
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165675 (2016)
Chronic kidney disease (CKD) is associated with reduced health-related quality of life (HRQL). However, the relationship between pre-dialysis CKD, HRQL and clinical outcomes, including mortality and progression to end-stage renal disease (ESRD) is un
Externí odkaz:
https://doaj.org/article/28fe97e5a73c43478a296b7d969312a0
Autor:
Khai P Ng, Stephanie J Stringer, Mark D Jesky, Punit Yadav, Rajbir Athwal, Mary Dutton, Charles J Ferro, Paul Cockwell
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91961 (2014)
Arterial stiffness is increased in patients with CKD and is a powerful predictor of cardiovascular morbidity and mortality. Use of the xanthine oxidase inhibitor allopurinol has been shown to improve endothelial function, reduce left ventricular hype
Externí odkaz:
https://doaj.org/article/8805d663e24e464791e136db553cbe40
Autor:
Nadezhda A, Wall, C Coral, Dominguez-Medina, Sian E, Faustini, Charlotte N, Cook, Andrew, McClean, Mark D, Jesky, Marisol, Perez-Toledo, Matthew D, Morgan, Alexandra G, Richter, Charles J, Ferro, Paul, Cockwell, Paul A, Moss, Ian R, Henderson, Lorraine, Harper, Adam F, Cunningham
Publikováno v:
PLoS ONE
Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c30050a4e19d59b0ea73a3d943877323
https://pubmed.ncbi.nlm.nih.gov/29659606
https://pubmed.ncbi.nlm.nih.gov/29659606